Back to Search
Start Over
Drug-dye-apoptosis inducing micelles for enhancing host immunity against advanced metastatic breast cancer by the combination of low dose chemotherapy and photothermal therapy
- Source :
- Journal of Industrial and Engineering Chemistry. 97:476-484
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Tumor metastasis is associated with high mortality in breast cancer patients. Although photothermal therapy (PTT) has arisen as a promising anticancer treatment approach, PTT-based monotherapies still fail to eradicate advanced cancers due to the immunosuppressive microenvironment. Herein, we synthesized drug-dye-lipid-like micelles composed of thermoresponsive poloxamer conjugated with linoleic acid (PCLA) loaded with a chemotherapeutic drug doxorubicin (DOX) and a near-infrared dye IR-780 (PCLA-ID) to enhance antitumor immunity against progressive metastatic breast cancers. Intravenous administration of sub-100 nm sized PCLA-ID in breast tumor-bearing mice followed by local laser irradiation eliminated not only primary tumors, but also untreated distant tumors (abscopal effect). The combinatorial treatment of apoptosis-inducing PCLA-ID, which contained DOX at a subtherapeutic dose, and PTT augmented the maturation of tumor-draining lymph nodes, the upregulation of cytotoxic T lymphocytes, and the suppression of regulatory T cells in untreated secondary tumors. These events prevented lung metastasis in tumor-bearing mice after re-challenging with a second injection of breast cancer cells. We conclude that PCLA-ID nanoparticles can enhance immunogenic cell death, representing a promising strategy for triggering immune responses against advanced metastatic breast cancers.
- Subjects :
- business.industry
General Chemical Engineering
Abscopal effect
02 engineering and technology
010402 general chemistry
021001 nanoscience & nanotechnology
medicine.disease
01 natural sciences
Metastatic breast cancer
0104 chemical sciences
Metastasis
Immune system
Breast cancer
Low-dose chemotherapy
Cancer research
Medicine
Immunogenic cell death
Doxorubicin
0210 nano-technology
business
medicine.drug
Subjects
Details
- ISSN :
- 1226086X
- Volume :
- 97
- Database :
- OpenAIRE
- Journal :
- Journal of Industrial and Engineering Chemistry
- Accession number :
- edsair.doi...........92f95f0616f788c65e6357bc30fd50c8